These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155 [TBL] [Abstract][Full Text] [Related]
3. In vivo studies of parathyroid gland function in secondary hyperparathyroidism. Salusky IB; Goodman WG Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632 [TBL] [Abstract][Full Text] [Related]
4. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Malberti F; Farina M; Imbasciati E Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664 [TBL] [Abstract][Full Text] [Related]
5. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034 [TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism. Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477 [TBL] [Abstract][Full Text] [Related]
7. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Combe C; Aparicio M Kidney Int; 1994 Nov; 46(5):1381-6. PubMed ID: 7853797 [TBL] [Abstract][Full Text] [Related]
8. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia. Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908 [TBL] [Abstract][Full Text] [Related]
9. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches. Ouseph R; Leiser JD; Moe SM J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients. Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487 [TBL] [Abstract][Full Text] [Related]
11. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Messa P; Mioni G; Turrin D; Guerra UP Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222 [TBL] [Abstract][Full Text] [Related]
13. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy. Schindler S; Mannstadt M; Urena P; Segre GV; Stein G Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031 [TBL] [Abstract][Full Text] [Related]
14. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism. Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644 [TBL] [Abstract][Full Text] [Related]
15. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032 [TBL] [Abstract][Full Text] [Related]
16. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism. Lu KC; Yeung LK; Lin SH; Lin YF; Chu P Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194 [TBL] [Abstract][Full Text] [Related]
17. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism. Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657 [TBL] [Abstract][Full Text] [Related]
18. Reversibility of experimental secondary hyperparathyroidism. Lewin E; Wang W; Olgaard K Kidney Int; 1997 Nov; 52(5):1232-41. PubMed ID: 9350646 [TBL] [Abstract][Full Text] [Related]
19. Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism. Ramirez JA; Goodman WG; Belin TR; Gales B; Segre GV; Salusky IB Am J Physiol; 1994 Dec; 267(6 Pt 1):E961-7. PubMed ID: 7810641 [TBL] [Abstract][Full Text] [Related]
20. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays. Santamaria R; Almaden Y; Felsenfeld A; Martin-Malo A; Gao P; Cantor T; Aljama P; Rodriguez M Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]